Image

Global Next-Generation Biomanufacturing Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Next-Generation Biomanufacturing Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jun 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Next-Generation Biomanufacturing Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 20.08 USD Billion
Diagram Market Size (Forecast Year) USD 42.58 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Next- Generation Biomanufacturing Market, By Workflow and Product (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing), Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others), End User (Commercial Stage, Preclinical and Development Stage) – Industry Trends and Forecast to 2029

Next- Generation Biomanufacturing Market

Market Analysis and Size

Artificial intelligence, machine learning, and augmented reality, among other advanced technologies, are used in next-generation biomanufacturing processes. When compared to the first-generation procedure, incorporating these technologies provides seamless, efficient, and high-quality results.

Data Bridge Market Research analyses that the next-generation biomanufacturing market which was USD 20.08 billion in 2021, would rocket up to USD 42.58 billion by 2029, and is expected to undergo a CAGR of 9.85% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Workflow and Product (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing), Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others), End User (Commercial Stage, Preclinical and Development Stage)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Illumina Inc. (US), Thermo Fischer Scientific Inc. (U.S), Oxford Nanopore Technologies plc (U.K), Agilent Technologies, Inc. (U.S), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (U.S), Hamilton Company (U.S), Macrogen Inc. (South Korea), Zymo Research Corporation(U.S), Tecan Trading AG (Switzerland) 

Market Opportunities

  • Increasing development and commercialization of digital bioreactors
  • Increasing Investment in R&D and rapid development of the biopharmaceutical industry

Market Definition

The rapid growth of the biopharmaceutical industry reflects the increasing relevance of biomanufacturing as the primary technique for the development and production of biological-based products, a market known as next-generation biomanufacturing.

Next-Generation Biomanufacturing Market Dynamics

Drivers

  • Adoption of advanced technology, and new innovation

Growth of the global biopharmaceutical sector, increased commercialization and pipeline development, adoption of advanced technology, and new innovation in design, efficiency, performance, and other areas are some of the factors that will likely boost the growth of the next-generation biomanufacturing market in the forecast period of 2020-2027. On the other hand, the availability of money from the government and private organisations for the development of novel technologies will increase the number of chances for the next-generation biomanufacturing market to grow throughout the projection period.

  • Rising environmental concerns

 The worldwide biomanufacturing market will be fueled by rising environmental concerns, pollution levels, water scarcity, and seamless services in the manufacturing of medication.

Plants that implement next-generation biomanufacturing will also increase demand for market share. Furthermore, the adoption of a single-use product strategy will aid in cost-cutting, product contamination reduction, and increased flexibility, resulting in a desire for next-generation biomanufacturing.

Increase in the number of biopharmaceutical businesses

In the forecast period, the next generation bio-manufacturing market is expected to be driven by an increase in the number of biopharmaceutical businesses around the world. The necessity for enhanced biomanufacturing to meet patient demand is projected to propel the next-generation biomanufacturing industry forward.

Opportunities

The development of a next-generation biomanufacturing process allows for the production of biological medication for the treatment of crucial ailments such as liver and kidney disease, cancer, and diabetes. Furthermore, increasing adoption of single-use products such as single-use bio-reactors and bio containers, as well as increasing financial support from private investors and governments for the development of next-generation biomanufacturing units, are among the major factors driving the global next-generation biomanufacturing market, which is expected to continue over the forecast period.

Restraints/Challenges

Huge capital expenditure, associated unpredictable costs, lack of skilled professionals, operational complexity and compatibility challenges are some of the factors which hinders the market growth.

This next-generation biomanufacturing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next-generation biomanufacturing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Next- Generation Biomanufacturing Market

The production of vaccines has become the primary focus of the biomanufacturing businesses as a result of the COVID-19 pandemic. Following the coronavirus pandemic, the development of improved vaccines will have an impact on the biopharmaceutical industry's growth. Scientists and engineers are currently concentrating their efforts on developing next-generation biomanufacturing systems that can create improved vaccines at a low cost. They're also concentrating on the vaccination quantities required to respond to future outbreaks and pandemics.

Recent Development

  • In April 2020, Cambryn Biologics in Sarasota, Florida, was bought by Akron Biotech. The facility is a biomanufacturing plant with cutting-edge technology.
  • In February 2020, Honeywell International Inc. teamed up with Bigfinite, Inc. to contribute to process automation and controls technologies, using Bigfinite's AI, data analytics, and machine learning platform to help the pharmaceutical and biotech sectors pace medicinal therapies.

Global Next- Generation Biomanufacturing Market Scope

The next-generation biomanufacturing market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Continuous Upstream Biomanufacturing
  • Single-Use Upstream Biomanufacturing
  • Downstream Biomanufacturing

Application

  • Monoclonal Antibodies
  • Hormones
  • Vaccines
  • Recombinant Proteins
  • Others

End-User

  • Biopharmaceutical Companies
  • Research Institutions
  • CMOs/CDMOs

Next- Generation Biomanufacturing Market Regional Analysis/Insights

The next-generation biomanufacturing market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.

The countries covered in the next-generation biomanufacturing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the next-generation biomanufacturing market due to the adoption of advanced technology and prevalence of various manufacturing companies in the region.

The growing surge in new capacity installations to meet the increased product demand in developing nations of Asia-Pacific is further expected to boost the next-generation biomanufacturing market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Next- Generation Biomanufacturing Market Share Analysis

The next-generation biomanufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to next-generation biomanufacturing market.

Some of the major players operating in the next-generation biomanufacturing market are:

  • Illumina Inc. (U.S)
  • Thermo Fischer Scientific Inc. (U.S)
  • Oxford Nanopore Technologies plc (U.K)
  • Agilent Technologies, Inc. (U.S)
  • BGI (China)
  • PerkinElmer Inc. (U.S)
  • QIAGEN (Germany)
  • Eurofins Scientific (Luxembourg)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Takara Bio Inc. (Japan)
  • GENEWIZ, Inc. (U.S)
  • Hamilton Company (U.S)
  • Macrogen Inc. (South Korea)
  • Zymo Research Corporation(U.S)
  • Tecan Trading AG (Switzerland) 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The next-generation biomanufacturing market size will be worth USD 42.58 billion by 2029.
The growth rate of the next-generation biomanufacturing market is 9.85% in the forecast by 2029.
Continuous upstream biomanufacturing, single-use upstream biomanufacturing, and downstream biomanufacturing are the factors on which the next-generation biomanufacturing market research is based.
Major companies in the next-generation biomanufacturing market are Illumina Inc. (US), Thermo Fischer Scientific Inc. (U.S), Oxford Nanopore Technologies plc (U.K), Agilent Technologies, Inc. (U.S), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (U.S), Hamilton Company (U.S), Macrogen Inc. (South Korea), Zymo Research Corporation(U.S), Tecan Trading AG (Switzerland).
Adoption of advanced technology, and new innovation, rising environmental concerns & Increase in the number of biopharmaceutical businesses are the growth drivers of the next-generation biomanufacturing market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials